OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions.
Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections.
In particular, the tool captures clinical outcomes in cases...
Myia Labs has raised $10 million in a Series A funding round led by Mercy Virtual, which pledged $5 million after deploying the startup’s AI and consumer wearable monitoring platform among its patients over the last few years.
Other investors in the round include Zetta Venture Partners, BootstrapLabs, Boston Consulting Group and B Capital Group, all of which participated in last year’s $6.75...
Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.
“Over the past few...
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses.
According to the announcement, Concerto’s eurekaHealth tool will “accelerate insights through novel health economic...
New York City-based Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $27 million in a funding round supported by new backers Sanofi, UCB, McKesson Ventures and Horizon Health Services, according to a release. Prior investors including NEA, Flare Capital and Lakestar also participated.
An add-on to prior funding from last year, today’s...
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche.
The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
